Kara Hanson SD

Head of GHD and Professor of Health System Economics

I am head of the Department of Global Health and Development, and a member of the Health Economics and Systems Analysis research group and of the LSHTM Malaria Centre.   My training is in development economics and health economics, and I have worked on health systems organisation and financing, mostly in sub-Saharan Africa, since 1988.  I have been working at LSHTM since 1997, and did my doctorate at the Harvard School of Public Health.

Affiliation

Teaching

I contribute to the teaching for Introduction to Health Economics and Economic Analysis for Health Policy. I tutor on the MSc in Public Health in Developing Countries.  My research degrees students are studying topics including professional training and physician retention in Malawi, health financing in Tanzania, and the role of private financing organisations in Nigeria.   

Research

My research has focused primarily on the economics of health systems in low- and middle-income countries. I have done research on hospital sector reforms in Uganda and Zambia, focusing on the implications of two-tier pricing for equity of access to hospital services. I am interested in the role of the private sector in health systems, and in identifying the opportunities and limitations of the private sector in improving the efficiency, quality and responsiveness of health systems.

I am co-Research Director of RESYST - Resilient and Responsive Health Systems, which is a UK-DFID funded research consortium bringing together researchers from South Africa, Nigeria, Kenya, Tanzania, Thailand, India, Vietnam and the UK. Our programme includes research on health financing, health workers and governance and leadership in the health sector.  

My second are of focus is the economics of malaria control interventions. In particular, I am interested in understanding better how to expand access to interventions that have been shown to be cost-effective. My current activities include ACTwatch, in which we are studying the supply chain for antimalarial drugs (http://www.actwatch.info/home/home.asp), undertaking economic evaluation of interventions addressing malaria in pregnancy (http://www.mip-consortium.org), and the Independent Evaluation of the Affordable Medicines Facility-malaria, which is an innovative financing mechanism for antimalarial drugs (http://www.theglobalfund.org/en/amfm/).  I lead a programme of economic evaluation of new interventions for malaria in pregnancy (www.mip-consortium.org), and am involved in a number of smaller projects including an economic evaluation of durable wall linings in Liberia with the Innovative Vector Control Consortium (www.ivcc.com).

Research areas

  • Health care financing
  • Health policy
  • Health sector development
  • Health services research
  • Health systems

Disciplines

  • Economics

Disease and Health Conditions

  • Malaria

Other interests

  • Health Economics
  • Hospital Reform
Back to top